ABSTRACT γ-amino butyric acid (GABA) is a non-protein amino acid widely distributed in nature. It has analgesic effect, promotes growth hormone secretion and prevents the physiological function of Alzheimer's disease.In order to improve the yield of GABA, the strain of strain HX-3-6 was tested by Atmospheric and Room Temperature Plasma (ARTP), and the strain with more than 90% lethality was selected for fermentation, and through the gradient plate according to the level of GABA concentration and colony size of the screening. Then, use the fermentation medium for re-screening and genetic stability test. The yield of the mutant strain L-120-1 was 5.828 g/L, which was 18.84% higher than that before the mutation (4.904). The mutant strain L-120-1 was used as the starting strain for ARTP mutagenesis. The yield of the stable mutant strain 90s-high was 6.178g / L, which was 16.15% higher than that before the mutation (5.319g / L). The yield of HX-3-6 strain was higher than that of GABA mutant strain 90s-high 2, which was stable and high yield GABA was 25.98%.
Introduction γ-amino butyric acid (GABA) is a non-protein amino acid widely distributed in plants and animals, and has many important physiological functions. In plants, γ-aminobutyric acid (GABA) is involved in the process of plant resistance to stress, stress response to pests and diseases. In animals, GABA acts as a major inhibitory neurotransmitter in the central nervous system of mammals, participates in the physiological activity of the brain cycle, reduces blood pressure, treats epilepsy, sedates, promotes sleep, enhances memory, controls asthma, regulates hormone secretion, promote reproductive, renal and liver function activation and other functions, is widely used in food, medicine and other industries. Therefore, the mechanism of its preparation, research has become a hotspot. At present, mainly through the fermentation of E. coli production of GABA, but the existence of E. c oli health and safety aspects of the great hidden dangers. Therefore, it is of great signifi cance to obtain high-yield GABA-safe new strain by mutagenesis [1 -3] .
In the food and pharmaceutical industry, the use of recognized safety probiotics -lactic acid bacteria for fermentation production GABA has a broader prospect, the current industrial production of GABA production is low [4, 5] , so to improve the GABA production in this experiment using plasma Breeding Breeding of Lactic Acid Bacteria.
UV is one of the most commonly used eff ective physical mutagenic factors, the mutagenic eff ect is mainly due to its changes in DNA structure and the formation of mutations [6] . However, UV induction has the problems of heavy breeding process and poor mutation.
Chemical mutagenesis is carried out by the use of chemical mutagenic agents which molecular structure is not stable, which causes biological damage and false repair by chemical agents, resulting in mutants [7] . But the chemical mutation breeding process is complex and has a relatively large harm to the human body operating environment. In this study, a new microbial mutation breeding method-atmospheric and room temperature plasma (ARTP) mutagenesis breeding system was adopted. ARTP is a kind of plasma source developed in recent years, and can produce plasma jet with high activity particle concentration between 25-40 ℃ and atmospheric temperature. The plasma has the characteristics of low temperature, high electron temperature, balance characteristics and high activity ion concentration characteristics. According to scientifi c research, the active particles in the plasma act on microorganisms, which can change the structure and permeability of microbial cell wall, membrane and cause gene damage, and thus make the microbial gene sequence and its metabolic network signifi cantly change, leading to microbial production mutation [8] .
ARTP mutagenesis breeding system has the advantages of safe operation, simple process, high mutation rate and economic environmental protection. Therefore, this experiment uses ARTP to mutagenize the lactobacillus producing GABA. The mutant strain with mutant GABA then the genetic stability test was carried out by using the fermentation medium to obtain the stable mutant strain of GABA.
1. Introduction
Research Status of γ-Aminobutyric Acid
GABA in food research and application began in the mid-eighties of last century, the application of products to Japan tea drink Gabaron as the representative. Gabaron tea drink with primary hypertension in mice, a few weeks found that blood pressure from 175-180 mmHg reduced to 150 mmHg, while no other physiological abnormalities of mice [9] . In 1994, Takayo et al. found that the accumulation of GABA in fermented germs was high at 200-300 mg/100 g [10] when studying the amino acid distribution of rice germs immersion in water. In 1996, GABA-rich rice germ products were commercialized in Japan. Neurophysiology and neurological studies have shown that GABA is an important active substance in the human brain, although GABA can be from the brain glutamate in the specifi city of glutamate decarboxylase under the action of transformation, but age and mental stress increase the diffi culty of GABA accumulation, and through daily diet supplement can eff ectively improve the situation, thereby promoting human health [11] .
Recently, Japanese scientists use rice germ and other raw materials developed and manufactured GABA-rich functional ingredients, has been widely used in beverages, jams, cakes, biscuits, seasonings and other products. It is also reported that high concentrations of GABA beverages made from biotechnology and GABA-rich food ingredients made from lactic acid bacteria can be used directly or as functional foods for anti-hypertension, brain function and liver function. China's GABA food research and development reports rarely, this research and development is still in its infancy.
1.2. Atmospheric pressure at room temperature plasma mutagenesis system
Basic principles of ARTP biological breeding
Atmospheric pressure low temperature plasma is a new type of plasma source which began to study in recent years. It has the advantages of low gas temperature, high active particle concentration, high energy and easy operation. Basic experimental studies have shown that high concentrations of active particles in atmospheric and low temperature plasmas can act on the genetic material of microorganisms and produce teratogenic mutations in a short time, which is a good source of mutagenesis [12] . Compared with traditional physical mutagenesis methods (such as ion beam implantation, radiation mutagenesis) and chemical mutagenesis methods, atmospheric and low temperature plasma mutagenesis methods are safe, simple, have no side eff ects on the human body, and no pollution to the environment.
ARTP development advantages
Conventional mutagenesis breeding methods have chemical mutation breeding and physical mutation breeding. Microbial mutagenesis breeding, mainly by means of artifi cial mutagenesis to induce microbial gene mutation, thereby changing the genetic structure and function, and then through the screening, from a lot of mutant bacteria in the selection of the required high yield, excellent traits of mutations And the optimum culture medium and the optimum culture conditions were found, so that it could synthesize the desired product under the optimum environmental conditions. Tsinghua University, Department of Plasma Health Science and Technology Research Group (Department of Engineering Physics), Environmental Biotechnology Laboratory (Department of Chemical Engineering) Beijing Siqingyuan Biotechnology Co., Ltd., using the international advanced atmospheric pressure low temperature plasma generation technology, combined with recent years. The latest research results and automatic control methods, jointly developed a second generation ARTP biological breeding machine. The breeding machine has the advantages of stable operation, no preheating, simple operation, good human-computer interaction performance, and can produce atmospheric temperature and low temperature plasma in the industrial environment to induce mutagenesis, accelerate the process of mutagenesis and improve the industrial production effi ciency [13] .
ARTP mutagenesis research can promote the integration and cross of plasma and biological science, on the one hand to promote multi-parameter, high-throughput, more controllable multi-channel atmospheric pressure low temperature plasma technology equipment development and innovation. On the one hand, through the study of diff erent biomolecules and species regulation and action methods, the formation of plasma biotechnology (Plasma biotechnology) new research fi eld -life sciences.
According to the meaning and meaning
γ-amino butyric acid (GABA) is a non-protein amino acid, which is an inhibitory transmitter in the mammalian center. GABA has the advantages of lowering blood pressure, enhancing memory, activating renal function, improving liver function, preventing and treating obesity, nutrition, nerve cells and other functions [14] , through the microbial fermentation method to obtain GABA is of great signifi cance.
With the GABA physiological function characteristics gradually recognized by human beings, the use of GABA enrichment technology to develop GABA-rich health food products will be a promising research field, chemical synthesis of GABA less safe, less GABA content in plant, the use of biosynthesis in the microbial (lactic acid bacteria) fermentation production GABA shows a broad development prospects [15] . However, the industrial production of GABA produced by lactic acid bacteria fermentation is not high.
In view of the fact that UV mutation breeding has the problems of heavy breeding process and poor mutation eff ect, chemical mutation breeding process is complex and has a large operating environment with great harm to human body.
In this study, the lactic acid bacteria were mutagenized by the new mutagenesis technique (atmospheric temperature chamber temperature mutagenesis breeding system), and the lactic acid bacteria strains with high yield GABA were obtained.
The main content of this study
(1) In this experiment, lactic acid bacteria producing γ-aminobutyric acid, which had been screened in the laboratory, were subjected to room temperature plasma mutagenesis at room temperature, and the mutants were screened by gradient plate.
(2) Fermentation of a large number of mutant strains in order to obtain lactic acid bacteria with high growth rate and high yield of γ-aminobutyric acid.
Experimental Materials

Source of bacteria
By the Anhui Wuhu Anhui University of Biotechnology Laboratory, No. HX-3-6. This test also supplies: Eppendorf centrifuge tube, beaker, glass rods, tweezers, reagent bottles, measuring cylinders, bottles, asbestos, cones, petri dishes, scissors, white wok, alcohol lamp, tube rack, ice bag, reagent spoon , Coated rods, glycerin tubes and so on. (1) Activation of the strain: After the standard stock was removed and returned to room temperature, 1 mL of lactic acid bacteria were inoculated with 10 mL (v / v) in 50 mL Erlenmeyer flask containing 9 mL of MRS liquid seed medium. Placed in 30 ℃ incubator for 24 hours.
Experimental drugs
Preparation of culture medium and related reagents
(2) Lactobacillus growth curve was drawn: The activated suspension was removed and inoculated with 10% (v / v) inoculated with 1 mL of the bacterial suspension to a 50 mL Erlenmeyer fl ask containing 9 mL of MRS liquid medium, incubation in the incubator, every 3h with a spectrophotometer at 600nm conditions measured bacteria OD value, and the time for the abscissa, OD value for the vertical axis of the growth curve of lactic acid bacteria.
The pH of the lactic acid bacteria suspension was also measured with a pH meter.
ARTP mutagenesis
(1) Preparation of the suspension: After the standard stock was removed and returned to room temperature, 1 mL of the lactic acid bacteria was inoculated into a 50 mL Erlenmeyer fl ask containing 9 ml of MRS liquid seed medium at 10% (v / v) And then centrifuge for 5 minutes, centrifuge to remove the supernatant by adding 1mL of sterile water using the oscillator to shake (1) uniformly, made of bacteria suspension reserve.
(2) ARTP mutagenesis operation: 10 μL of the above prepared bacteria suspension was applied to sterilized small iron pieces (8 groups in total) using a 20 μL pipetting on a sterile console. Eight groups of bacteria were subjected to ARTP processing time is 0s, 30s, 60s, 90s, 120s, 150s, 180s, 210s and 240s.
Atmospheric pressure room temperature (ARTP) plasma mutation breeding device, in this experiment using the conditions described below; power supply: 220V, 50Hz, voltage fl uctuation range ≤ 5%, gas fl ow selection 10SLM, temperature 20 -40 ℃ below, power 200W.
Use the tweezers to place the sample to be placed in the fi xed groove on the rotating positioning table, and then adjust the height of the rotary table so that the sample to be processed is 3 mm away from the plasma generator outlet and the sample is closed and closed operate room door, select the irradiation time.
Post-culture and plate count
(1) Post-culture: The mutated microfuel containing the bacterial solution was quickly placed in a centrifuge tube containing 1.5 mL of MRS liquid medium, and the mutated lactic acid bacteria were then placed in a thermostatic incubator at 30 °C 2h.
(2) Plate count: 2h after the removal of mutagenic bacteria using the oscillator to centrifuge tube bacteria in the mix, with 1000μL pipette to draw 0.5mL placed in 4.5mL saline with 7mL centrifuge tube, followed by dilution To 10-3,10-4,10-5,10-6, take the dilution fold 10-4,10-5 two gradient bacteria suspension (0s take the dilution factor of 10-5,10-6 two gradient bacteria coated plate), with 100 μL of the 200 μL pipettes, add MRS plates, apply evenly, and each dilution was done in three parallel lines. The coated plates were placed in a thermostatic incubator and incubated at 30 °C for 72 h.
(3) Calculation of ARTP lethality: After 72 hours of culture, the colonies on the plate were counted and compared with the corresponding concentration of the control group, according to the formula: lethality = (control groupmutagenic colonies)/control number of colonies, calculated lethality.
Screening of mutants
(1) Preparation of gradient plate: In the aseptic console, the plate tilted about 15 degrees, put about 10mL MRS agar medium, to be solidifi ed and put back to the horizontal position, and then pour into the same volume of GABA concentration 60 g/L MRS medium, after solidifi cation to form a gradient plate back.
(2) Screening of mutant strains: The mutant strains were diluted 10-4,10-5 with gradient plates, and the coated gradient plates were placed in a constant temperature incubator and incubated at 30 ℃ for 72 hours (0s no need to coat the gradient plate). The colony size was determined by GABA concentration and colony size after 72 hours of culture. The relationship between colony size and anti-GABA concentration and GABA production was verifi ed.
(3) Mutation of the mutant strain: The mutant strain was re-screened with the fermentation medium, and the fermentation conditions were 50 mL of a 250 mL Erlenmeyer fl ask. And cultured at 30 ℃ for 72 h at room temperature. After 72 h, the yield of GABA was measured by measuring the mutant strain at 640 nm.
Determination of GABA content
Take 1ml fermentation broth in 1.5mL centrifuge tube 10000 r/min centrifugation 2min, draw 0.5mL supernatant diluted with sterile water 10 times standby.
Take 0.8 mL of the stock solution in a fl at bottom tube. Then, 0.2 mL of 0.2 mol/L sodium carbonate solution, 0.2 mL of a borate buff er of 0.2 mol/L Ph10.0, and 2.5 mL of 6% re-distilled phenol were added, followed by addition of 2 mL of sodium hypochlorite (NaClO). Mix and place for 4 to 8 minutes, then boiling water bath for 10min, immediately ice bath for 20min, until the solution appears blue and green, add 4mL 60% ethanol solution, mix room temperature after 3 minutes 20 min, after the solution is made from 200 μL of each solution was added to the plate, and the content of GABA was determined by the microplate reader at 640 nm. The GABA standard was determined by a microplate reader. 
Species preservation
The mutant strains of high yield GABA obtained by repeated screening and repeated passage were frozen and frozen at -70 ℃ with glycerol tubules.
3.2. Breeding of lactic acid bacteria L-120-1 by ARTP 3.2.1 Source of the strain L-120-1 was the mutant strain of HX-3-6 strain that was mutated by ARTP and screened with hereditary and yield stable.
Basic operation of the experimental process
The activation of the strain → the growth curve of the lactic acid bacteria → the preparation of the bacterial suspension → the induction of ARTP → the post-culture → the plate count → the calculation of the lethal rate of the ARTP → the screening of the mutant strain → the determination of the GABA content → the preservation of the strain. Lactic acid bacteria HX-3-6 lactic acid bacteria after activation treatment, the use of spectrophotometer in A600 under the conditions of HX-3-6 lactic acid bacteria growth curve shown in Figure 4 -1, the figure can be seen, the bacteria after inoculation culture After a short period of adaptation into the logarithmic growth period, about 18h into the logarithmic period, during which the cell growth and metabolism of strong and stable is the best time to mutagenesis. At the same time we can see that the strain enters the stable phase after about 21 hours.
Determination of lethal rate of lactic acid bacteria HX-3-6
Figure 3. HX-3-6 mutagenic lethality curve It can be seen from Figure 4 -2: HX-3-6 lactic acid bacteria after ARTP mutagenesis treatment, lactic acid bacteria mutagenesis rate increases with the strain mutation time increases. 90s mortality rate of 77.81%, 120s lethal rate of 91.2%; experiment to select the lethality of 90% of the strains were screened in order to obtain high-yield strains. Figure 4 . Yield of GABA after HX-3-6 mutagenesis As can be seen from Figure 4 -3, after the fi rst mutagenesis, it was found that the yield of GABA was increased with most of the mutated strains compared with the control group; the yield of 120-1 GABA was 5.828 g / L; The highest yield of GABA mutant strain l-120-1 was 18.84% higher than that before mutagenesis. And after several generations of yield stability. Figure 4 -4, it can be seen from the fi gure, the bacteria in the vaccination after a short period of adaptation into the logarithmic growth period, about 14h into the logarithmic period, during this period Cell growth and metabolism is strong and stable is the best time to mutagenesis. At the same time we can see that the strain enters the stable phase after about 18h
Determination of GABA content after HX-3-6 mutagenesis
Lactobacillus growth curve and HX-3-6 lactic acid bacteria growth curve is diff erent. Lactic acid bacteria L-120-1 after the activation of the above steps, the use of pH meter to determine the lactic acid bacteria L-120-1 culture pH change shown in Figure 4 -4, in the incubation time of 0 -24h culture between the pH The value has been reduced from 6.5 to 5.0. The pH value of L-120-1 was signifi cantly diff erent from that of HX-3-6 culture, and the pH and growth curve of L-120-1 were correlated, probably due to genetic changes caused by the results. Figure 6 . L-120-1 mutagenic lethality curve It can be seen from Figure 4 -5: L-120-1 lactic acid bacteria after ARTP mutagenesis treatment, lactic acid bacteria mutagenic mortality rate increases with the mutation time of the strain increased. The lethal rate of lactic acid bacteria strain was 95.8% at 90 s mutation time, and the mutant strain on 90s gradient plate was screened and screened.
L-120-1 lethality determination
4.2.3
Determination of GABA content at 90s after L-120-1 mutagenesis Figure 7 . L-120-1 mutant strain GABA content and OD curve
In Figure 4 -6, 90s-low 1,90s represents the time of mutation, low on the low concentration of GABA (medium to medium concentration, high for high concentration), 1 for larger colonies (2 for moderate colonies, 3 for smaller colonies). From Fig. 4-6 , it can be seen that the yield of GABA produced by 90s-high 1,90s-high 2 mutant was signifi cantly higher than that of control group after L-120-1 lactic acid bacteria mutagenesis. The yield was 6.116g / L, 6.178g / L, respectively, and the yield of GABA was 14.98% and 16.15%, respectively.
In this study, the strain with high yield and high GABA yield was obtained, but the OD value of the mutant strain was not correlated with the yield of GABA, and the higher yield of GABA did not show a higher OD value. , pending further mutagenesis screening.
Conclusions
The purpose of microbial breeding is to guide the biosynthetic metabolic pathways in the direction that people want, or to optimize genetic traits after mutations in the cells, artifi cially accumulate some metabolites excessively and achieve the high yield, high quality and low consumption of bacteria. Gene mutations are one of the most important pathways and have been widely used [16] . At present, the domestic microbial breeding industry is mainly used in conventional physical, biological and chemical factors such as mutagenesis methods to reorganize. This experiment is through the new mutagenesis method -atmospheric pressure plasma temperature (ARTP) mutation breeding system. Through this experiment, the following conclusions are drawn:
(1) From the growth curve of HX-3-6 lactic acid bacteria before the fi rst mutation, the logarithmic phase of the strain was obtained at 3 -21h and about 18 hours later, the best timing for mutation. The mutant L-120-1 yield was 5.828 g/L, which was 18.84% higher than that of the original strain.
(2) The growth curve of lactic acid bacteria HX-3-6 measured in this experiment is diff erent from that of lactic acid bacteria L-120-1, which may be the change of gene after lactic acid bacteria mutagenesis.
(3) In this experiment, the mutant strain with the highest GABA yield was 25.98% higher than that of the original lactic acid bacteria strain HX-3-6, which was obtained by mutagenizing the Lactobacillus strain L-120-1.
(4) The Lactobacillus strain L-120-1 was mutagenized, and single colonies were selected from the three high, medium and low concentrations on the gradient plate. The yield of the 90s-high 2 mutant strain was the highest, and the yield of L-120-1 (5,319 g/L) was 16.15% higher than that before mutagenesis.
Due to lack of time, the quality of GABA lactic acid bacteria that produced in the end of experiment is not ideal enough, it is recommended to carry out further works for improvement:
(1) Mutant breeding of mutant strains by UV mutation breeding and chemical mutation breeding in order to obtain high yield GABA lactic acid bacteria mutant strains.
(2) Mutagenesis combined with high-throughput screening to improve the effi ciency of screening mutants, to obtain high-yield strains.
(3) To study the mechanism and principle of high yield induced by mutagenesis in combination with genetic engineering.
